BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17722311)

  • 21. Contraceptive efficacy and side effects of Implanon.
    Gezginc K; Balci O; Karatayli R; Colakoglu MC
    Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):362-5. PubMed ID: 17853166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of norethindrone acetate in the treatment of symptomatic endometriosis.
    Muneyyirci-Delale O; Karacan M
    Int J Fertil Womens Med; 1998; 43(1):24-7. PubMed ID: 9532466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience.
    Graesslin O; Korver T
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():4-12. PubMed ID: 18330813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion.
    Kang L; Gong J; Cheng Z; Dai H; Liping H
    J Minim Invasive Gynecol; 2009; 16(2):169-73. PubMed ID: 19249704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen.
    Vercellini P; Frontino G; De Giorgi O; Pietropaolo G; Pasin R; Crosignani PG
    Fertil Steril; 2003 Sep; 80(3):560-3. PubMed ID: 12969698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A randomized study comparing the efficacy and bleeding pattern of Implanon and Norplant hormonal contraceptive implant].
    Yao XY; Du MK
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):419-22. PubMed ID: 12921554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open and randomized study comparing the efficacy of standard danazol and modified triptorelin regimens for postoperative disease management of moderate to severe endometriosis.
    Wong AY; Tang L
    Fertil Steril; 2004 Jun; 81(6):1522-7. PubMed ID: 15193471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate.
    Vercellini P; Pietropaolo G; De Giorgi O; Pasin R; Chiodini A; Crosignani PG
    Fertil Steril; 2005 Nov; 84(5):1375-87. PubMed ID: 16275232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study.
    Ferrero S; Camerini G; Ragni N; Venturini PL; Biscaldi E; Remorgida V
    Hum Reprod; 2010 Jan; 25(1):94-100. PubMed ID: 19820247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of levetiracetam in the treatment of lumbar radiculopathy: an open-label prospective cohort study.
    Hamza MS; Anderson DG; Snyder JW; Deschner S; Cifu DX
    PM R; 2009 Apr; 1(4):335-9. PubMed ID: 19627916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand.
    Kiriwat O; Patanayindee A; Koetsawang S; Korver T; Bennink HJ
    Eur J Contracept Reprod Health Care; 1998 Jun; 3(2):85-91. PubMed ID: 9710712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.
    Riney S; O'Shea B; Forde A
    Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial.
    Santamato A; Solfrizzi V; Panza F; Tondi G; Frisardi V; Leggin BG; Ranieri M; Fiore P
    Phys Ther; 2009 Jul; 89(7):643-52. PubMed ID: 19482902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria.
    Mutihir JT; Nyango DD
    East Afr Med J; 2010 Nov; 87(11):461-4. PubMed ID: 23457809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can we decrease breakthrough bleeding in patients with endometriosis on norethindrone acetate?
    Muneyyirci-Delale O; Jalou S; Rahman M; Nacharaju V
    Int J Fertil Womens Med; 2003; 48(1):32-6. PubMed ID: 12643518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bladder endometriosis: laparoscopic treatment and follow-up.
    Granese R; Candiani M; Perino A; Venezia R; Cucinella G
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):114-7. PubMed ID: 18462860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests -- a randomized comparative study with Norplant implants.
    Biswas A; Biswas S; Viegas OA
    Contraception; 2004 Nov; 70(5):379-82. PubMed ID: 15504376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buserelin acetate implants in the treatment of pain in endometriosis.
    Choktanasiri W; Rojanasakul A
    J Med Assoc Thai; 2001 May; 84(5):656-60. PubMed ID: 11560214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.